$RBLX

Roblox (RBLX) Stock Plunges After Jefferies Issues Sell Rating

Roblox (RBLX) shares fell 4.6% premarket after Jefferies downgraded the stock to Underperform with a $38 price target, citing concerns over spending and margin pressure. The stock had risen 30% since Q2 results, but Jefferies sees no fundamental support. Analysts' opinions diverge, with Morgan Stanley maintaining an Overweight rating and a $55 target.

Original reporting
Published Sep 28, 2026, 11:56 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 12:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Roblox (RBLX) Stock Plunges After Jefferies Issues Sell Rating — source image
Decision brief

The 30-second read

$RBLXBearishHigh
01

Why it matters

Analyst downgrade highlights margin pressure and user growth concerns, likely prompting short‑term sell pressure.

02

Market read

Roblox’s stock faces immediate downside risk following a fresh downgrade, while divergent analyst views create a split outlook.

03

What to watch

Recent AI‑powered creation tools and advertising initiatives could improve future revenue streams.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Roblox reported Q2 bookings of $1.57 bn, near the low end of guidance, and posted a 30% share rally since the results.

Company-level read

Ticker impact

$RBLXBearishHigh confidence
Context

Jefferies downgraded Roblox to Underperform with a $38 price target, citing weak bookings and margin pressure.

Expected impact

downward pressure as investors reassess bookings growth and margin outlook

Evidence & confidence

Analyst downgrade with a concrete price target and recent pre‑market sell-off indicates a material shift in sentiment.

Market effects

Potential drag on other gaming and metaverse stocks as analysts scrutinize growth spending.

U.S. tech sector may see modest pullback in the near term.

Limited to investors focused on U.S. growth‑stage tech equities.

Counterpoint

Morgan Stanley maintains an Overweight stance with a $55 target, suggesting upside if bookings rebound.

Key entities

  • Jefferies

    Issued Underperform rating and $38 price target.

  • Morgan Stanley

    Maintains Overweight rating with $55 target.

Related articles

$RBLXMed

DSA Designation of ChatGPT, Reddit and Roblox Sets Four-Month Compliance Clock

The European Commission designated ChatGPT, Reddit, and Roblox as Very Large Online Platforms or Search Engines under the Digital Services Act, requiring compliance by January 2027. Each must conduct risk assessments, audits, and face oversight. ChatGPT, classified as a Very Large Online Search Engine, has over 159 million EU users. Non-compliance may result in fines up to 6% of global turnover.

$RBLXHigh

Roblox Stock Falls After Jefferies Cuts It to Underperform

Roblox (RBLX) shares dropped 5.56% after Jefferies downgraded it to Underperform with a $38 price target, citing concerns over user growth and bookings. The firm expects a slower recovery in U.S. and Canada users, attributing past growth to viral games with short retention. Oppenheimer maintains an Outperform rating and $50 target, anticipating AI tools at RDC 2026.

$RBLXMed

Jefferies Downgrades Roblox (RBLX) to Underperform on Bookings Growth Risk

Jefferies downgraded Roblox (RBLX) to Underperform, maintaining a $38 price target. The firm cites concerns over bookings growth, arguing recent recovery prices in unrealistic expectations. Roblox shares have risen 30% since a 27% drop post-Q2 results. The company's bookings, not earnings, are key to valuation, with revenue recognized over time. Jefferies' downgrade is based on current player spending trends, not yet reflected in reported results.

$RBLXMed

Market movers: MongoDB, Snowflake, Nvidia, NextSource

Roblox Corp was downgraded to "underperform" by Jefferies, with a $38 price target. NextSource Materials secured a $30M investment for its Abu Dhabi facility. Kodiak Sciences shares surged 162% after positive trial results. IonQ received a Buy rating and $60 target from Bank of America. MongoDB's shares fell 18% following CEO departure. Nvidia authorized $150B in additional share repurchases. Snowflake plans a $3.5B convertible notes offering.